Posted on 05/26/2020 3:22:40 PM PDT by Jan_Sobieski
Washington has purchased nearly a third of the initial one billion doses of AstraZeneca’s experimental coronavirus vaccine.
The U.S. Department of Health has agreed to provide up to US$1.2 billion to fast-track AstraZeneca’s vaccine development while securing 300 million doses for the entire US reports MDLinx. The vaccine is being developed from a laboratory at Oxford University.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” U.S. Health Secretary Alex Azar said.
AstraZeneca is collaborating with Microsoft, to launch an artificial intelligence (AI) ‘Factory for Health’. One of the startups in the ‘factory’ is Kap Code. The tech company created a tool based on a method of hypnosis called Neuro-Linguistic Programming (NLP). The start-up scans social media posts and uses that data to better understand patient experiences. Microsoft was founded by Gates. He is now among the company’s top shareholders.
(Excerpt) Read more at breakingisraelnews.com ...
I’ll never be persuaded that there is a replacement for displacement.
Last vaccine shot I had was as a kid for measels, chicken pox, etc. No reason to restart now.
Over by The Reitz?
24 May: UK Independent: Coronavirus: Oxford vaccine ‘has only 50-per-cent chance of success’
‘We’re in the bizarre position of wanting Covid to stay, at least for a little while,’ says researcher
by Harry Cockburn; Additional reporting by Press Association
Project leader Professor Adrian Hill, of the university’s Jenner Institute, said the realisation of a working vaccine was far from guaranteed and cautioned against “over promising”, in an interview with The Sunday Telegraph.
But the warning has not deterred pharmaceutical giant AstraZeneca, which announced a $1.2bn (£986m) deal to produce 400 million doses of the vaccine first created in Professor Hill’s Oxford lab.
Pascal Soriot, the chief executive of the drug company, told The Andrew Marr Show on Sunday that British people would be among the first to gain access to the vaccine, which could be ready by September.
Mr Soriot said: “Yes, we have actually received an order from the British government to supply 100 million doses of vaccine, and those will go to the British people.
“And there’s no doubt, starting in September, we will start delivering these doses of vaccine to the British government for vaccination.”...
But Mr Soriot said the vaccine being rolled out in autumn would still depended on two factors – firstly that the drug works, and secondly that there remains a sizeable proportion of the population in the country with Covid-19 – otherwise it will be difficult to demonstrate the efficacy of the inoculation...
“The vaccine has to work and that’s one question, and the other question is, even if it works, we have to be able to demonstrate it. We have to run as fast as possible before the disease disappears so we can demonstrate that the vaccine is effective.”
The Jenner Institute and the Oxford Vaccine Group began development on a vaccine in January, using a virus taken from chimpanzees.
Following an initial phase of testing on 160 healthy volunteers between 18 and 55, the study is now set to progress to phases two and three, which involve increasing the testing to up to 10,260 people and expanding the age range of volunteers to include children and the elderly...
Professor Hill told The Sunday Telegraph that if the virus’s spread was too low, not enough of the volunteers will catch it and the trial will be unable to definitively say if the vaccine works.
“It’s a race against the virus disappearing, and against time,” Professor Hill said. “We said earlier in the year that there was an 80-per-cent chance of developing an effective vaccine by September. But at the moment, there’s a 50-per-cent chance that we get no result at all.
“We’re in the bizarre position of wanting Covid to stay, at least for a little while.”
https://www.independent.co.uk/news/science/coronavirus-vaccine-oxford-university-uk-astrazeneca-a9530606.html
the Telegraph article - which is behind paywall - is published here:
24 May: Sydney Morning Herald: Low virus rate leaves Oxford vaccine trial with ‘only 50% chance’
By Bill Gardner, UK Telegraph
London: An Oxford University vaccine trial has only a 50 per cent chance of success because coronavirus is fading so rapidly in Britain, a project co-leader has warned...
“We’re in the bizarre position of wanting COVID to stay, at least for a little while. But cases are declining.”...
https://www.smh.com.au/world/europe/low-virus-rate-leaves-oxford-vaccine-trial-with-only-50-percent-chance-20200524-p54vvu.html
“I’ll never be persuaded that there is a replacement for displacement.”
10.6 second quarter mile off the showroom floor from a 5.2 in a 4000 pound car might persuade you?
“Over by The Reitz?”
Yep.
My street racing days are long behind me!
I don’t remember the 60’s, so maybe you’re right...
Amen! Toujours Pret!
It’s not Gates conspiracy. It’s Gates fact. Available for all to see on a simple search.
Gates just had to cancel his company’s promotion of Marina Abramovic because of the backlash. Here is an article where he admits to being a witch... https://macdailynews.com/2019/07/18/bill-gates-steve-jobs-was-a-wizard-who-cast-spells-on-people/
You’re being sarcastic, right? If not, carry on. Without me.
Congrats! Must have taken all of your remaining brain cells and a 12 pack to find this exquisite response.
Lol! Truth hits people in different ways. Mostly bouncing off dullards
“Congrats! Must have taken all of your remaining brain cells and a 12 pack to find this exquisite response.”
Nope. Just googled ‘Jan_Sobieski’.
Keep reading. You might learn something.
After the first vaccination you’ll have to take regular updates as those come out. Put it on your schedule.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.